Save your place

Sign in to WhoBought

Please try again later.

Joel Greenblatt's Apellis Pharmaceuticals, Inc. (APLS) position

Yes: as of Q1 2026, Joel Greenblatt holds 79K shares of APLS worth $3.2M (0.0% of the disclosed portfolio). Last quarter the position was reduced by 53.3%. First disclosed Q3 2022.
View full portfolio →
Current value
$3.2M
Shares held
79K
% of portfolio
0.0%
Est. average buy price (i)
$23.46
est. since Q4 2025
Quarter-end price
$40.23

Estimated trade prices

Average price in quarters with purchases
$24.67
Average prices in quarters with sales
  • Q1 2026: $21.55 (90K shares sold)
  • Q2 2023: $86.28 (1K shares sold)

APLS price vs Greenblatt's position

Dates
$10$50$10020222023202420252026New position of 4K shares · Q3 2022. Average closing price $59.17 · Price range $44.76–$68.674KsharespurchasedNew position of 4K shares · Q1 2023. Average closing price $57.70 · Price range $46.59–$66.964KsharespurchasedSold 1K shares (29.4%) · Q2 2023. Average closing price $86.28 · Price range $76.68–$93.311KsharessoldNew position of 4K shares · Q4 2023. Average closing price $50.73 · Price range $37.14–$64.824KsharespurchasedNew position of 24K shares · Q4 2024. Average closing price $30.07 · Price range $26.18–$35.4224KsharespurchasedAdded 10K shares (41.1%) · Q1 2025. Average closing price $27.62 · Price range $21.87–$34.6310KsharespurchasedAdded 85K shares (247.8%) · Q2 2025. Average closing price $18.51 · Price range $16.36–$23.0085KsharespurchasedAdded 8K shares (6.7%) · Q3 2025. Average closing price $23.32 · Price range $17.42–$28.658KsharespurchasedSold 90K shares (53.3%) · Q1 2026. Average closing price $21.55 · Price range $16.97–$40.2390Ksharessold
Average closing price · filing quarter
$21.55
Price range · filing quarter
$16.97 – $40.23

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Reduced −90K −$1.9M −53.3% 79K May 15, 2026
Q4 2025 First covered 168K Feb 17, 2026
Q3 2025 Added +8K +$185K +6.7% 127K Nov 14, 2025
Q2 2025 Added +85K +$1.6M +247.8% 119K Aug 14, 2025
Q1 2025 Added +10K +$276K +41.1% 34K May 15, 2025
Q4 2024 New +24K +$731K 24K Feb 14, 2025
Q1 2024 Unchanged 4K May 15, 2024
Q4 2023 New +4K +$178K 4K Feb 14, 2024
Q2 2023 Reduced −1K −$98K −29.4% 3K Aug 14, 2023
Q1 2023 New +4K +$222K 4K May 15, 2023
Q3 2022 New +4K +$264K 4K Nov 14, 2022
Data through Q1 2026 · filed May 15, 2026
11 grouped rows from 11 quarters

More Greenblatt positions

Common questions

Does Joel Greenblatt own APLS?

Yes. As of Q1 2026, Joel Greenblatt disclosed 79K shares of APLS, worth $3.2M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Joel Greenblatt buy APLS?

Joel Greenblatt first disclosed a APLS position in Q3 2022; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Joel Greenblatt sell APLS?

The quarter-by-quarter table above shows each sale and reduction Joel Greenblatt disclosed in APLS. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of APLS does Joel Greenblatt own?

Joel Greenblatt disclosed 79K shares of APLS as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Joel Greenblatt pay for APLS?

Joel Greenblatt began building the APLS position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.